Evidence map›Paper›PMID 30410196›Full record

ArticleColombia medica (Cali, Colombia)2018

22q11.2 deletion detected by

Azubel Ramírez-Velazco, Horacio Rivera, Ana Isabel Vásquez-Velázquez, Thania Alejandra Aguayo-Orozco, Saturnino Delgadillo-Pérez, Maria Guadalupe Domínguez

Open access · greenAbstract read
In one paragraph

Article in Colombia medica (Cali, Colombia), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Azubel Ramírez-VelazcoDoctorado en Genética Humana - CUCS-, Universidad de Guadalajara, Guadalajara, México.
Horacio RiveraDoctorado en Genética Humana - CUCS-, Universidad de Guadalajara, Guadalajara, México.
Ana Isabel Vásquez-VelázquezDivisión de Genética - CIBO. Instituto Mexicano del Seguro Social, Guadalajara, México.
Thania Alejandra Aguayo-OrozcoDoctorado en Genética Humana - CUCS-, Universidad de Guadalajara, Guadalajara, México.
Saturnino Delgadillo-PérezHospital de Pediatría- UMAE-CMNO, Instituto Mexicano del Seguro Social, Guadalajara, México.
Maria Guadalupe DomínguezDivisión de Genética - CIBO. Instituto Mexicano del Seguro Social, Guadalajara, México.
Mexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDeletion 22q11.2 occurs in 1:4,000-1:6,000 live births while 10p13p14 deletion is found in 1:200,000 newborns. Both deletions have similar clinical features such as congenital heart disease and immunological anomalies.

objectiveWe looked for a 22q11.2 deletion in Mexican patients with craniofacial dysmorphisms suggestive of DiGeorge or velocardiofacial syndromes and at least one major phenotypic feature (cardiac anomaly, immune deficiency, palatal defects or development delay).

methodsA prospective study of 39 patients recruited in 2012-2015 at the Instituto Mexicano del Seguro Social at Guadalajara, Mexico. The patients with velocardiofacial syndrome-like features or a confirmed tetralogy of Fallot (TOF) or complex cardiopathy were studied by G-banding and fluorescence

resultsTwenty-two patients (7 males and 15 females) had the 22q11.2 deletion and 17/39 did not have it; no patient had a 10p loss. Among the 22 deleted patients, 19 had congenital heart disease (mostly TOF). Twelve patients without deletion had heart defects such as TOF (4/12), isolate ventricular septal defect (2/12) or other disorders (6/12).

conclusionIn our small sample about ~56% of the patients, regardless of the clinical diagnosis, had the expected 22q11.2 deletion. We remark the importance of early cytogenetic diagnosis in order to achieve a proper integral management of the patients and their families.

Indexed as

In Situ Hybridization, FluorescenceAdolescentChildChild, PreschoolCytogenetic AnalysisDiGeorge SyndromeFemaleHeart Defects, CongenitalHeart Septal Defects, VentricularHumansInfantMaleMexicoProspective StudiesTetralogy of FallotYoung Adult22q11.2 deletioncongenital heart defects.craniofacial abnormalitiesDiGeorge syndromeTetralogy of Fallotvelocardiofacial syndrome

Identifiers

PMID30410196
PMCPMC6220481
OpenAlexW2899461756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.